Bud Selig

Weiner: the 50-100-lifetime suspension rules don’t apply to Biogenesis

35 Comments

We were really thrown a curveball earlier today when MLBPA head Michael Weiner, addressing the media, said that the penalties facing Biogenesis-implicated players are not ruled by the Joint Drug Agreement’s 50-game, 100-game, lifetime ban specifications.  When asked about why that was, Weiner pointed to the Commissioner’s “just cause” powers under the JDA.

Which seems odd to me because, as Wendy Thurm pointed out earlier today, the JDA says this about discipline:

A player who tests positive for a Performance Enhancing Substance, or otherwise violates the Program through the possession or use of a Performance Enhancing Substance, will be subject to the discipline set forth below. (emphasis mine) 1. First violation: 50-game suspension; 2. Second violation: 100-game suspension; 3. Third violation: Permanent suspension from Major League and Minor League Baseball.

That italicized language seems to say that the discipline regime applies whether it’s a testing positive or, as will be the case with Biogenesis, non-analytical positives, circumstantial evidence-based violations, etc. There’s nowhere else in the agreement which speaks to Commissioner discretion with respect to discipline beyond the mere words “just cause,” which again, seems to speak to the violation, not the discipline.

Could this be a negotiated thing? The union and the league having an understanding, either now or having had it always, about what might happen if they’re dealing with a non-testing-based violation? And no matter when it was decided that any amount of discipline could apply for such violations, could it not mean that some guys get less than 50 games? Some way more.

As an example: say a Biogenesis Player — let’s call him Theo Blonzalez — has very weak evidence against him in the documents and testimony, but that the league wants to discipline him anyway. Might they take this discretion and give him, say, a five game suspension? That might be a nice break for someone like Blonzalez who, otherwise, might be subject to an automatic 50, which would seem overly harsh. At the same time, might another player with stronger evidence against him — say Schmalex Rodriguez — be slapped with unlimited discipline even if it’s a first offense?

I don’t know what it means, frankly. But I find it fascinating. And it further underscores my suspicion that a lot more conversations are happening between the union and the league than we know about. And that, just maybe, it’s nowhere near as adversarial as we might think.

Report: Mariners acquire Chris Heston from the Giants

Leave a comment

Jon Morosi of MLB Network and FOX Sports reports that the Mariners have acquired starter Chris Heston from the Giants. The Giants will receive a player to be named later, per Jon Heyman of FanRag Sports.

Heston, 28, logged only five innings in the majors this past season as he battled an oblique injury and otherwise spent most of his time with Triple-A Sacramento. Heston was solid out of the Giants’ rotation in 2015, posting a 3.95 ERA with a 141/64 K/BB ratio in 177 2/3 innings over 31 starts.

Heston will be under team control through 2021. He’ll provide depth for the Mariners’ rotation in the meantime.

Joe Nathan wants to pitch in 2017

DETROIT, MI - AUGUST 16: Joe Nathan #36 of the Detroit Tigers pitches in the ninth inning of the game against the Seattle Mariners at Comerica Park on August 16, 2014 in Detroit, Michigan. The Tigers defeated the Mariners 4-2.  (Photo by Leon Halip/Getty Images)
Leon Halip/Getty Images
2 Comments

Joe Nathan‘s agent, David Pepe, says his client wants to pitch in 2017, per ESPN’s Jerry Crasnick. “He’s like the Energizer Bunny,” Pepe said.

Nathan, 42, came back from Tommy John surgery in July, pitching two scoreless innings for the Cubs with four strikeouts and two walks. The Cubs released him and the Giants picked him up, and Nathan went on to pitch 4 1/3 scoreless innings down the stretch with five strikeouts and two walks.

According to FanGraphs, Nathan’s velocity wasn’t where it used to be, which is to be expected of a pitcher in his 40’s coming back from major elbow surgery. Still, with teams always on the hunt for bullpen depth, it would be shocking if Nathan didn’t get any bites before spring training starts.